MENU
VIRX Viracta Therapeutics Chart, History Price & Graph
a developer of oncology therapeutics for treatment of solid and hematologic cancers
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
VIRX and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, VIRX has been loosely correlated with MRNS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VIRX jumps, then MRNS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To VIRX | 1D Price Change % | ||
|---|---|---|---|---|
| VIRX | 100% | +11.42% | ||
| MRNS - VIRX | 40% Loosely correlated | +2.14% | ||
| VNDA - VIRX | 27% Poorly correlated | -3.97% | ||
| SPRO - VIRX | 25% Poorly correlated | -2.19% | ||
| CTMX - VIRX | 25% Poorly correlated | -5.08% | ||
| IMMP - VIRX | 24% Poorly correlated | -3.80% | ||
More | ||||
Groups containing VIRX
Correlation & Price change
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To VIRX | 1D Price Change % |
|---|---|---|
| VIRX | 100% | +11.42% |
| treatment theme (61 stocks) | 14% Poorly correlated | +0.91% |
| therapeutics theme (57 stocks) | 11% Poorly correlated | +20.54% |
| drugs theme (265 stocks) | 10% Poorly correlated | +5.37% |
| biotechnology theme (248 stocks) | 8% Poorly correlated | +5.56% |
| oncology theme (18 stocks) | 4% Poorly correlated | +0.37% |